Key terms
About ALHC
Alignment Healthcare, Inc. operates as a holding company. The company offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The firm offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered Orange, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ALHC news
Apr 23
8:27am ET
Alignment Healthcare price target lowered to $9 from $11 at Stifel
Apr 02
10:58am ET
Insurer stocks tumble as Medicare Advantage rates disappoint
Apr 01
4:35pm ET
CMS finalizes payment update for 2025 Medicare Advantage, sees payments up 3.7%
Mar 06
7:12am ET
Piper downgrades Alignment Healthcare to Neutral following mixed Q4 results
Mar 06
6:35am ET
Barclays starts health care facilities, managed care group with Neutral view
Mar 06
5:52am ET
Alignment Healthcare downgraded to Neutral from Overweight at Piper Sandler
Mar 05
4:25pm ET
Alignment Healthcare initiated with an Underweight at Barclays
Mar 01
1:06am ET
Buy Rating Affirmed for Alignment Healthcare Amidst Strong Q4 Performance and Positive 2024 Outlook
Feb 29
5:40am ET
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD)
Feb 28
9:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 28
7:48am ET
Alignment Healthcare (ALHC) Receives a Buy from TD Cowen
Feb 27
4:14pm ET
Alignment Healthcare reports Q4 EPS (25c), consensus (22c)
Feb 01
6:36am ET
Alignment Healthcare price target lowered to $8.50 from $10.50 at Stephens
ALHC Financials
Key terms
Ad Feedback
ALHC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ALHC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range